Latham & Watkins Advises Artelon in Acquisition by Stryker

Stryker (NYSE: SYK), a global leader in medical technologies, has announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures. The acquisition will strengthen Stryker’s offerings in the soft tissue fixation segment and highlights Stryker’s commitment to providing differentiated solutions for ligament and tendon reconstruction. This transaction is subject to customary closing conditions.

Latham & Watkins LLP represents Artelon in the transaction with a corporate deal team led by Boston partner Hans Brigham and counsel Stefanie Vincent, with associates Michael Casagrande and Sydney France. Advice was also provided on tax matters by Bay Area partner Grace Lee, with associates Derek Gumm and Dennis Poehland; on intellectual property matters by Boston partner Sarah Gagan, with associates Matthew Snyder and Alex Theuer;* on data privacy matters by Bay Area partner Heather Deixler, with associate Mitch Bennett; on executive compensation, employment, and benefits matters by Boston partner Josh Friedman and Chicago partner Nineveh Alkhas, with associate Rebecca Fishbein; on healthcare regulatory matters by Washington, D.C. partner Jason Caron, with associate Leia Gu; on US antitrust matters by Washington, D.C. partners Amanda Reeves and Patrick English; on OUS antitrust matters by Brussels partner Hector Armengod; and on FDA matters by Washington, D.C. counsel Chad Jennings.

*Admitted to practice in New York.